Genomic diversity and BCL9L mutational status in CTC pools predict overall survival in metastatic colorectal cancer
Alves, J. M.; Estevez-Gomez, N.; Pineiro, R.; Muinelo-Romay, L.; Mondelo-Macia, P.; Salgado, M.; Iglesias-Gomez, A.; Codesido-Prada, L.; Diez-Martin, A.; Cubiella, J.; Posada, D.
Show abstract
The genomic diversity of circulating tumor cells (CTCs) and its clinical implications remain poorly understood. In this study, we characterized the mutational landscape of CTC pools stemming from 29 metastatic colorectal cancer (mCRC) patients and examined its relationship with disease progression. Our analysis revealed substantial variation in mutational burden among patients, with all CTC pools harboring non-silent mutations in key CRC driver genes. Importantly, higher genomic diversity in CTC pools was significantly associated with reduced overall survival. Furthermore, non-silent mutations in BCL9L emerged as a strong predictor of patient survival. Taken together, these findings underscore the potential of CTC genomic profiling as a promising prognostic tool in mCRC and highlight the need for further research into its clinical applications.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- De novo detection of somatic variants in high-quality long-read single-cell RNA sequencing data 94%
- Long-read RNA sequencing redefines the clear cell renal cell carcinoma transcriptome and reveals novel genes and transcripts associated with disease recurrence and immune evasion 93%
- Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing 92%
Similar papers in this journal
- Genome profiles of lymphovascular breast cancer cells reveal multiple clonally differentiated outcomes with multi-regional LCM and G&T-seq 94%
- Evaluation of homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional tissue-based immunofluorescence assays 94%
- Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.